SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-23-030389
Filing Date
2023-06-20
Accepted
2023-06-20 08:02:11
Documents
90

Document Format Files

Seq Description Document Type Size
1 425 ny20008526x7_425.htm 425 34561
2 EXHIBIT 99.1 ny20008526x7_ex99-1.htm EX-99.1 26582
3 EXHIBIT 99.2 ny20008526x7_ex99-2.htm EX-99.2 168527
4 ny20008526x7_ex99-1image01.jpg GRAPHIC 2952
5 ny20008526x7_ex99-1image02.jpg GRAPHIC 3488
6 ny20008526x7_ex99-2slide1.jpg GRAPHIC 63157
7 ny20008526x7_ex99-2slide2.jpg GRAPHIC 103531
8 ny20008526x7_ex99-2slide3.jpg GRAPHIC 495981
9 ny20008526x7_ex99-2slide4.jpg GRAPHIC 234590
10 ny20008526x7_ex99-2slide5.jpg GRAPHIC 103531
11 ny20008526x7_ex99-2slide6.jpg GRAPHIC 138097
12 ny20008526x7_ex99-2slide7.jpg GRAPHIC 117749
13 ny20008526x7_ex99-2slide8.jpg GRAPHIC 97747
14 ny20008526x7_ex99-2slide9.jpg GRAPHIC 104170
15 ny20008526x7_ex99-2slide10.jpg GRAPHIC 102160
16 ny20008526x7_ex99-2slide11.jpg GRAPHIC 62674
17 ny20008526x7_ex99-2slide12.jpg GRAPHIC 209486
18 ny20008526x7_ex99-2slide13.jpg GRAPHIC 177520
19 ny20008526x7_ex99-2slide14.jpg GRAPHIC 158599
20 ny20008526x7_ex99-2slide15.jpg GRAPHIC 179804
21 ny20008526x7_ex99-2slide16.jpg GRAPHIC 195290
22 ny20008526x7_ex99-2slide17.jpg GRAPHIC 175188
23 ny20008526x7_ex99-2slide18.jpg GRAPHIC 65103
24 ny20008526x7_ex99-2slide19.jpg GRAPHIC 74792
25 ny20008526x7_ex99-2slide20.jpg GRAPHIC 86102
26 ny20008526x7_ex99-2slide21.jpg GRAPHIC 97233
27 ny20008526x7_ex99-2slide22.jpg GRAPHIC 133609
28 ny20008526x7_ex99-2slide23.jpg GRAPHIC 156378
29 ny20008526x7_ex99-2slide24.jpg GRAPHIC 172531
30 ny20008526x7_ex99-2slide25.jpg GRAPHIC 161104
31 ny20008526x7_ex99-2slide26.jpg GRAPHIC 173266
32 ny20008526x7_ex99-2slide27.jpg GRAPHIC 152817
33 ny20008526x7_ex99-2slide28.jpg GRAPHIC 36515
34 ny20008526x7_ex99-2slide29.jpg GRAPHIC 129222
35 ny20008526x7_ex99-2slide30.jpg GRAPHIC 124414
36 ny20008526x7_ex99-2slide31.jpg GRAPHIC 160794
37 ny20008526x7_ex99-2slide32.jpg GRAPHIC 178513
38 ny20008526x7_ex99-2slide33.jpg GRAPHIC 217970
39 ny20008526x7_ex99-2slide34.jpg GRAPHIC 46056
40 ny20008526x7_ex99-2slide35.jpg GRAPHIC 168829
41 ny20008526x7_ex99-2slide36.jpg GRAPHIC 144275
42 ny20008526x7_ex99-2slide37.jpg GRAPHIC 232188
43 ny20008526x7_ex99-2slide38.jpg GRAPHIC 128727
44 ny20008526x7_ex99-2slide39.jpg GRAPHIC 131008
45 ny20008526x7_ex99-2slide40.jpg GRAPHIC 57295
46 ny20008526x7_ex99-2slide41.jpg GRAPHIC 122970
47 ny20008526x7_ex99-2slide42.jpg GRAPHIC 131864
48 ny20008526x7_ex99-2slide43.jpg GRAPHIC 209792
49 ny20008526x7_ex99-2slide44.jpg GRAPHIC 140856
50 ny20008526x7_ex99-2slide45.jpg GRAPHIC 151943
51 ny20008526x7_ex99-2slide46.jpg GRAPHIC 106710
52 ny20008526x7_ex99-2slide47.jpg GRAPHIC 101987
53 ny20008526x7_ex99-2slide48.jpg GRAPHIC 36006
54 ny20008526x7_ex99-2slide49.jpg GRAPHIC 39944
55 ny20008526x7_ex99-2slide50.jpg GRAPHIC 36810
56 ny20008526x7_ex99-2slide51.jpg GRAPHIC 124013
57 ny20008526x7_ex99-2slide52.jpg GRAPHIC 77727
58 ny20008526x7_ex99-2slide53.jpg GRAPHIC 37784
59 ny20008526x7_ex99-2slide54.jpg GRAPHIC 73123
60 ny20008526x7_ex99-2slide55.jpg GRAPHIC 103443
61 ny20008526x7_ex99-2slide56.jpg GRAPHIC 115397
62 ny20008526x7_ex99-2slide57.jpg GRAPHIC 35235
63 ny20008526x7_ex99-2slide58.jpg GRAPHIC 95878
64 ny20008526x7_ex99-2slide59.jpg GRAPHIC 84994
65 ny20008526x7_ex99-2slide60.jpg GRAPHIC 37659
66 ny20008526x7_ex99-2slide61.jpg GRAPHIC 83147
67 ny20008526x7_ex99-2slide62.jpg GRAPHIC 102022
68 ny20008526x7_ex99-2slide63.jpg GRAPHIC 123209
69 ny20008526x7_ex99-2slide64.jpg GRAPHIC 134882
70 ny20008526x7_ex99-2slide65.jpg GRAPHIC 103521
71 ny20008526x7_ex99-2slide66.jpg GRAPHIC 34434
72 ny20008526x7_ex99-2slide67.jpg GRAPHIC 104588
73 ny20008526x7_ex99-2slide68.jpg GRAPHIC 79239
74 ny20008526x7_ex99-2slide69.jpg GRAPHIC 39638
75 ny20008526x7_ex99-2slide71.jpg GRAPHIC 108360
76 ny20008526x7_ex99-2slide72.jpg GRAPHIC 33713
77 ny20008526x7_ex99-2slide73.jpg GRAPHIC 114837
78 ny20008526x7_ex99-2slide74.jpg GRAPHIC 86930
79 ny20008526x7_ex99-2slide76.jpg GRAPHIC 85804
80 ny20008526x7_ex99-2slide77.jpg GRAPHIC 102835
81 ny20008526x7_ex99-2slide78.jpg GRAPHIC 88107
82 ny20008526x7_ex99-2slide79.jpg GRAPHIC 113235
83 ny20008526x7_ex99-2slide80.jpg GRAPHIC 85041
84 ny20008526x7_ex99-2slide81.jpg GRAPHIC 36588
85 ny20008526x7_ex99-2slide82.jpg GRAPHIC 104263
86 ny20008526x7_ex99-2slide84.jpg GRAPHIC 86238
87 ny20008526x7_ex99-2slide85.jpg GRAPHIC 89905
88 ny20008526x7_ex99-2slide86.jpg GRAPHIC 68741
89 ny20008526x7_ex99-2slide88.jpg GRAPHIC 138286
90 ny20008526x7_ex99-2slide89.jpg GRAPHIC 46951
  Complete submission text file 0001140361-23-030389.txt   13756703
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filed by) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Subject) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-31141 | Film No.: 231023442
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences